Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study.
Wencong LiJing LiangJihong AnLingdi LiuYihui HouLu LiWen ZhaoLuyao CuiNingning XueZaid Al-DhaminTao HanYue-Min NanLiaoyun ZhangPublished in: Canadian journal of gastroenterology & hepatology (2022)
Genotypes 1b and 2a were dominant subtypes in North and Northeast China. The approved drug regimens EBR/GZR and SOF/LDV for subtype 1b and SOF/VEL for nongenotype 1b are the optimal effective and safety profile.